CCNB1 and breast carcinoma: Furthermore, CCNB1 overexpression contributes to resistance to radiotherapy in head and neck squamous cell carcinoma [71], and nuclear cyclin B1-positive breast carcinomas are resistant to adjuvant therapy [73].